Biotech · Private company
Apollo Therapeutics Ltd
Track this companyFree. Adds Apollo Therapeutics Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- CamoteskimabPhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- APL-5125Phase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Camoteskimab (CERC-007, AVTX-007, AEVI-007)Phase 1 · Adult Onset Still's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisPHASE2 · RECRUITING · started May 28, 2026ClinicalTrials.gov NCT07599813 · fetched Nov 12, 2026
- A Study to Investigate APL-5125 in Adults With Advanced Solid TumorsPHASE1 · COMPLETED · started Jun 18, 2024ClinicalTrials.gov NCT06399757 · fetched Nov 12, 2026
- A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic DermatitisPHASE2 · COMPLETED · started May 1, 2024ClinicalTrials.gov NCT06436183 · fetched Nov 12, 2026
- A Study to Evaluate Camoteskimab in Participants With Still's DiseasePHASE1 · TERMINATED · started Mar 25, 2021ClinicalTrials.gov NCT04752371 · fetched Nov 12, 2026